Combining Bupropion (Wellbutrin) with Citalopram
Yes, combining bupropion with citalopram is appropriate and well-supported for treating major depressive disorder, particularly when monotherapy has been inadequate. This combination is commonly used in clinical practice and has demonstrated superior efficacy compared to switching strategies or continuing monotherapy alone.
Pharmacokinetic Compatibility
The FDA drug label data confirms this combination is pharmacologically sound. Citalopram does not affect the pharmacokinetics of bupropion or its three metabolites 1. However, bupropion increases citalopram's Cmax and AUC by 30% and 40%, respectively 1. This interaction is generally well-tolerated and does not contraindicate combination use—it simply means the citalopram may have slightly higher blood levels, which can be managed through standard monitoring.
Clinical Evidence for Combination Therapy
Treatment-Resistant Depression
The combination of citalopram and bupropion-SR is more effective than switching to monotherapy in patients who haven't responded to initial treatment 2. In a cohort study of 61 patients with treatment-resistant depression:
- Combination therapy achieved 28% remission vs. 7% with monotherapy switching (p <0.05)
- Greater symptom improvement (SIGH-SAD change score: -14.8 vs. -10.1, p <0.04)
- No greater side effect burden than monotherapy 2
First-Line Combination Approach
When initiated together from the start of treatment, this combination shows advantages:
- Superior speed of onset: 18% remission at week 2 with combination vs. 0% with either monotherapy (p=0.02-0.03) 3
- Week 12 remission rate of 54% with combination vs. 27% with bupropion alone (p=0.04) 3
- Open-label studies report 50-62% remission rates with this combination 4
Complementary Mechanisms
The combination works through distinct pathways:
- Citalopram: Selective serotonin reuptake inhibition
- Bupropion: Dopamine/norepinephrine reuptake inhibition 5
This dual mechanism addresses different symptom clusters effectively. Recent analysis shows bupropion is particularly effective for hypersomnia, increased appetite, weight gain, and fatigue 6, while SSRIs like citalopram address core depressive and anxiety symptoms.
Practical Implementation
Dosing Strategy
From the evidence:
- Citalopram: Start 10 mg/day, can increase to 20-40 mg/day 4
- Bupropion-SR: Add at week 1, starting 150 mg/day, can increase to 400-450 mg/day 3, 4
- Mean effective doses: citalopram 18 mg/day, bupropion-SR 327-329 mg/day 4
When to Use This Combination
Preferred scenarios:
- Inadequate response to SSRI monotherapy (most common indication) 2, 7
- SSRI-associated sexual dysfunction (bupropion can reverse this) 7
- Residual symptoms on monotherapy, particularly fatigue, hypersomnia, or weight gain 6
- First-line treatment in chronic/recurrent depression when rapid response is desired 3
Safety Considerations
Key contraindications for bupropion:
- Seizure disorders (lowers seizure threshold) 5, 8
- Bulimia or active eating disorders 9
- Uncontrolled hypertension 9
- Concurrent MAOI use (within 14 days) 10
Monitor for:
- Blood pressure and heart rate (bupropion can increase both) 9
- Neuropsychiatric effects, especially in patients <24 years 10
- Insomnia (give second bupropion dose before 3 PM) 5
Special Populations
Depression with anxiety: This combination is appropriate; guidelines note that lorcaserin and naltrexone/bupropion should be used with caution in depression, but bupropion alone with SSRIs is not restricted 9.
Older adults: Citalopram is a preferred agent for older patients 11. The bupropion-citalopram combination has been studied across ages 18-83 without age-related concerns 1.
Bottom Line
The combination of bupropion and citalopram is pharmacologically compatible, clinically effective, and generally well-tolerated. It offers superior outcomes compared to monotherapy switching in treatment-resistant depression and can be considered as a first-line approach in appropriate patients. The main precaution is monitoring for bupropion's effects on blood pressure and ensuring no contraindications (particularly seizure disorders) exist.